Renaud Bonnet

Practice Leader Private Equity

巴黎 + 33.1.56.59.39.14

聯絡

*Share

Renaud Bonnet is co-leader of Private Equity for the Firm's Corporate Practice. His practice areas include venture capital, private equity, M&A, and capital markets. He represents technology and life sciences companies, as well as the private equity and strategic investors that finance them, at every stage of development from entrepreneurial start-ups to multibillion dollar global corporations. He has acted as principal lawyer in a significant number of early to late-stage financing rounds, LBO and other M&A transactions, joint ventures, IPOs, rights issues, private placements, and tender offers.

Renaud's recent experience includes representations of technology and life sciences companies Adocia, Agicap, Bioptimus, Cellectis, Criteo, Contentsquare, CVE, Deezer, Devialet, EcoVadis, Ivalua, 360Learning, ManoMano, Nanobiotix, Ouihelp, Talend, and Voltalia. His recent investor-side representations include: Alven, BNP Paribas, Bpifrance, Creadev, Elaia, Eurazeo, Hi Inov, IDIA CI, Revaia, Sanofi, Seventure, Sofinnova, Temasek, and Tilt Capital.

Illustrative transactions in which Renaud acted as lead lawyer include: representing the issuer and/or underwriters in more than 100 IPOs and follow-on offerings; the IPOs of Criteo, Cellectis, Nanobiotix, and Talend on Nasdaq; the take-private of Completel, Wavecom, Assystem, and TxCell; the de-SPACs of Deezer and Arverne Group; the LBOs of HRA Pharma by Astorg and Goldman Sachs, Orolia by Eurazeo, A2Mac1 by Five Arrows, and Brico Privé by Florac; the sale of Novexel to AstraZeneca and Silicon Mobility to Intel; the acquisition of French technology companies by Ansys, Autodesk, Criteo, OVH, and SAP; and the latest financing rounds of Ivalua, EcoVadis, and Contentsquare.

Renaud was a member of the Consultative Commission on Issuers' Transactions and Financial Information of the French Financial Markets Authority (AMF) from 2017 to 2019.

執業經驗

  • Oscar sells Olféo to EkinopsJones Day advised the management and shareholders of Oscar (Olféo group), a French provider of Secure Service Edge cybersecurity software and web security gateways, in connection with the sale of the company to Ekinops, a French supplier of open and interoperable telecommunications solutions.
  • Bioptimus receives €41 million financingJones Day advised Bioptimus, the pioneering AI foundation model company, in its €41 million financing led by Cathay Innovation with participation from Sofinnova Partners, Bpifrance through its Large Venture Fund, Andera Partners, Hitachi Ventures, Boom Capital Ventures, Pomifer Capital, Sunrise, and angel entrepreneurs Emmanuel Cassimatis and Thomas Wolf.
  • VIALINK sold to SignaturitJones Day advised VIALINK in the sale of the company to PSG-backed Signaturit.
  • Kyotherm raises €300 millionJones Day advised Kyotherm, a co-developer and financer of renewable heat and energy efficiency projects, in connection with its €300 million financing led by InfraVia Capital Partners and existing investor, Andera Partners.
  • Consortium of investors leads Melvan's €25 million fundraisingJones Day advised a consortium of investors led by Bpifrance, IDIA Capital Investissement, a pool of other investors from the Crédit Agricole group, and OCCTE, in connection with the €25 million financing of Melvan, a French producer and developer of multi-technology renewable energies.
  • Agicap raises capital in €45 million Series C financingJones Day advised Agicap, the all-in-one Treasury management platform, in connection with its €45 million Series C financing led by AVP.
  • BNP Paribas participates in $640 million Series B financing of Mistral AIJones Day advised BNP Paribas in the $640 million Series B financing of Mistral AI, an AI-powered solutions company, including data entry systems and large language models.
  • Cellectis and AstraZeneca enter into research collaboration and agree on equity investment of up to $220 million by AstraZenecaJones Day advised Cellectis in connection with the joint research collaboration agreement entered into with AstraZeneca and initial equity investment by AstraZeneca into Cellectis of $80 million.
  • Silicon Mobility sold to IntelJones Day advised Silicon Mobility SAS in the acquisition of the company by Intel Corporation.
  • TiLT Capital Partners leads €46 million financing of EODevJones Day advised TiLT Capital Partners SAS in leading the €46 million financing of EODev, along with Supernova Invest, CapHorn, Pulse (CMA-CGM), and the existing shareholders of EODev, to strengthen its leading position in the hydrogen fuel cell power generators market by financing its investment program, the expansion of its product range, and the acceleration of its commercial development.
  • Contentsquare acquires HeapJones Day acted as French counsel to Contentsquare in the acquisition of Heap, a leading U.S. product analytics platform.
  • Arverne Group combines with Transition to publicly list on Euronext Paris the future French leader in geothermal and low-carbon lithium to drive energy transitionJones Day advised Arverne Group SAS, a French company ("Arverne"), in its business combination with Euronext listed Transition SA to create the future French leader in geothermal and low-carbon lithium production.
  • CVE raises €100 million from ICG InfraJones Day advised CVE, a France-based independent producer of renewable energy across multiple countries and sources of power, in connection with its €100 million financing round led by Intermediate Capital Group plc, a global alternative asset manager, through its infrastructure investment arm (ICG Infra).
  • Sofinnova and NVentures co-lead $55.4 million financing of Moon SurgicalJones Day advised Sofinnova Partners (through Sofinnova Capital Strategy) and NVentures (NVIDIA's venture capital arm) as lead investors in connection with the $55.4 million financing of Moon Surgical, a French-American pioneer in collaborative robotics.
  • Bpifrance (Large Venture) participates in $355 million Series D financing round of ExotecJones Day represented Bpifrance (Large Venture) in the $355 million Series D round of financing of Exotec, a provider of robotic solutions for warehouses, led by Goldman Sachs Asset Management, along with Bpifrance (Large Venture) and 83North, becoming the first French industrial unicorn.
  • EcoVadis completes $500 million fundraising, becoming 27th French unicornJones Day advised EcoVadis, a leading global sustainability rating firm, in connection with its $500 million fundraising.
  • Deezer merges with and into I2PO S.A.Jones Day advised Deezer S.A. in the context of the SPAC transaction whereby Deezer S.A. merged with and into I2PO S.A., a French SPAC listed on the professional segment of the regulated market of Euronext Paris and the related PIPE financing.
  • Nanobiotix completes $113.3 million IPO on NasdaqJones Day represented Nanobiotix S.A., a French clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, in connection with its $113.3 million initial public offering in the United States and listing on Nasdaq.
  • 360Learning raises $200 million in financing roundJones Day advised 360Learning, a French-based company having developed a collaborative learning SaaS platform to help companies unlock learning based on collective expertise, in connection with its $200 million round of financing led by Sumeru, Silver Lake, and Softbank.
  • Criteo completes IPO of American Depository Shares on NASDAQJones Day advised Criteo S.A., a France-based technology company specializing in performance display advertising, in connection with its issuance of $288 million of Ordinary Shares in an initial public offering in the form of American Depository Shares on NASDAQ.
    •

    March 2023 White Paper

    2022 Annual M&A/PE Review and 2023 Forecast

    January 2022 White Paper

    2021 Transactional Year in Review and 2022 Forecast

    January 2022 White Paper

    FDI Regimes Continue to Expand and Increase Scrutiny of Transactions Worldwide

    February 2021 White Paper

    2020 Transactions Year in Review

    June 2016 Alert

    Brexit: United Kingdom Votes to Leave the EU

    September 18-20, 2023 Speaking Engagements

    Jones Day lawyers to attend IPEM 2023

    • 29 janvier 2014
      Le private equity en 2014 : tendances et opportunités
    • 29 janvier 2013
      Le Private Equity : où en sommes-nous ?
    • 20 septembre 2012
      Le financement des PME: actualités juridiques et tendances de marché - en partenariat avec NYSE Euronext et Société Générale
    • September 20, 2012
      SME Financing: legal news and market trends – in collaboration with NYSE Euronext and Société Générale
    • 5 avril 2011
      Atelier « Fusions & Acquisitions » de France Biotech - Le point de vue de l'avocat, intervention de Renaud Bonnet
    • 17 juin 2009
      Introductions en bourse : la mission de l’avocat conseil et la problématique règlementaire, Conférence “Penser à votre introduction en bourse : osé ... mais peut-être astucieux ! ” organisée par la Société Générale
    • 3 avril 2007
      Introductions en bourse : feuille de route pratique
    • 18 mai 2006
      Petit déjeuner thématique "Stock options, BCE, actions gratuites"
    • 14 mars 2006
      Cours à l'ESSEC, "Mécanisme d'incitation des managers"

    *Before sending, please note:

    *Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.